Publication Date
5-2016
Abstract
A new poll of adults in the United States by Stat and Harvard T.H. Chan School of Public Health examines public opinion on provisions in the 21st Century Cures Act and a similar package in the Senate, which aim to speed up the process for developing new prescription drugs and medical devices. A majority of Americans do not favor these measures, after being told that changing government regulations could help make new drugs and devices available faster to patients, but could also increase the risk that therapies with harmful side effects or ones that are less effective could be approved for public use. Additionally, most adults do not believe these changes to accelerate the development and review process would lead to lower drug prices for consumers.
Policies that intend to increase competition in the U.S. pharmaceutical market by requiring the Food and Drug Administration (FDA) to reciprocally approve drugs from a list of designated countries, like those included in the Reciprocity Ensures Streamlined Use of Lifesaving Treatments (RESULT) Act, were also met with skepticism. More than three in five Americans believe the FDA should conduct its own reviews when considering whether to approve a drug for sale in the U.S. rather than relying on the testing standards of other nations.
ORCID
McMurtry, https://orcid.org/0000-0003-2617-7085
Language
English (en)
Originally Published In
Blendon, R. J., Benson, J. M., McMurtry, C. L., & Sayde, J. M. May 2016. “Americans’ Attitudes about Changing Current Prescription Drug and Medical Device Regulation.” Harvard Opinion Research Program report for STAT News.
Recommended Citation
Blendon, R. J.; Benson, J. M.; McMurtry, Caitlin L.; and Sayde, J. M., "Americans’ Attitudes about Changing Current Prescription Drug and Medical Device Regulation" (2016). Brown School Faculty Publications. 81.
https://openscholarship.wustl.edu/brown_facpubs/81
Document Type
Report
Comments
The Harvard Opinion Research Program (HORP) produces a series of nationwide polls on current health and medicine issues conducted in partnership between Harvard T.H. Chan School of Public Health and STAT News.